9 March 2021 – Guido Grentzmann, CEO and CSO of Opterion Health AG, shared insights on our new osmotic driver for Peritoneal Dialysis (PD) at the recent virtual ISPD (International Society for Peritoneal Dialysis)-EuroPD Joint Conference:
Common PD fluids use glucose as osmotic driver (ODR) at concentrations between 1% and 5%. The high glucose concentration of conventional PD fluids leads to high initial osmotic pressure. The back-diffusion of glucose, from the dialysate into the patient’s bloodstream, presents a metabolic challenge.
At Opterion, we aim to improve Quality of Life of PD patients by:
– Providing a solutions and dwells that can be easily adapted to the patient’s ultrafiltration needs.
– Reducing the metabolic burden of PD and thus cardiovascular risks.
– Decreasing peritoneal fibrosis to prolong the time window of PD therapy.
– Better adaption of dwell cycles to the patient’s lifestyle.